SAMSUNG-ELECTRONICS
14.5.2024 10:01:29 CEST | Business Wire | Press release
SiPearl, the company building the high-performance low-power European microprocessor for HPC and AI inference, has signed a partnership with Samsung Electronics Co. Ltd., a world leader in advanced memory technology, to equip its Rhea series with Samsung’s advanced memory solution ideal for HPC and AI applications.
After an extensive market survey, SiPearl has selected the global leading technology company Samsung, and its High-Bandwidth Memory (HBM) for its outstanding speed and energy-efficiency combined with a reduced thermal resistance.
This collaboration will enable SiPearl to leverage Rhea family best-in-class performance and energy-efficiency for HPC and AI inference workloads.
“We are excited to contribute to the expansion of SiPearl’s unique supercomputer/AI ecosystem with Samsung’s advanced HBM technology,” said Yongcheol Bae, Executive Vice President and Head of Memory Product Planning at Samsung Electronics. “As the HPC and AI market grows and diverse requirements increase, high-performance, high-bandwidth, low-power solutions are key to support development of the Rhea series in the future. We are committed to delivering memory solutions that can bring superior performance and efficiency for future HPC and AI applications in a close collaboration with SiPearl.”
“At SiPearl, we are thrilled to be a European pioneer in the use of HBM technology in conjunction with Samsung Electronics. Combining our high-performance, low-power microprocessor technologies with built-in HBM is key to meet all the requirements of supercomputing and AI inference workloads. On the fast-growing AI inference market, we think that our product will be a market leading solution for inference Large Language Model (LLM) tasks providing among other things high flexibility to model changes relative to solutions currently in use ”, concluded Philippe Notton, CEO and founder of SiPearl.
About… SiPearl
SiPearl is building the European high-performance low-power microprocessor dedicated to supercomputing and AI inference. This new generation of microprocessors will first target EuroHPC Joint Undertaking ecosystem, which is deploying world-class supercomputing infrastructures in Europe for solving major challenges in medical research, security, energy management and climate with a reduced environmental footprint.
SiPearl is working in close collaboration with its 30 partners from the European Processor Initiative (EPI) consortium - leading names from the scientific community, supercomputing centres and industry - which are its stakeholders, future clients and end-users.
SiPearl employs more than 190 people in France (Maisons-Laffitte, Grenoble, Massy, Sophia Antipolis), Germany (Duisburg), Italy (Bologna) and Spain (Barcelona).
About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry, and LED solutions.
For the latest news, please visit the Samsung Newsroom at news.samsung.com.
(1) HPC : High Performance Computing |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514089129/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs21.4.2026 14:00:00 CEST | Press release
Partnership enables timely access to botensilimab plus balstilimab through France’s government-reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named-patient programs (NPP) in select countries Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and BAP Pharma, a global medicines access and clinical trial supply company, today announced the exclusive appointment of BAP Pharma as Agenus’ global partner for botensilimab (BOT) plus balstilimab (BAL) authorized global access programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421146539/en/ The partnership supports compliant, patient-focused access to BOT+BAL through authorized pathways where permitted by local regulations. Effective immediately, BAP Pharma will serve as Agenus’ exclusive partner for the coordination of BOT+BAL global access program operations, including program requests, case coordination, distribution logistics, and re
Textron Aviation Announces Fleet Order From LUMINAIR to Operate Nine Best-selling Cessna Citation Latitude Midsize Business Jets, Supporting Charter Operations Across Europe21.4.2026 13:42:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced at AERO Friedrichshafen it has entered into a purchase agreement with LUMINAIR, a private jet operator in Europe, to operate nine Cessna Citation Latitude business jets. Renowned for its exceptional features, versatility, impressive range and operating economics, the best-selling midsize business jet was selected by LUMINAIR to support their increasing demand and enhance their mission flexibility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420434515/en/ Textron Aviation announces fleet order from LUMINAIR to operate nine best-selling Cessna Citation Latitude midsize business jets, supporting charter operations across Europe. (Photo credit: Textron Aviation) “The Citation Latitude is exceptionally well suited to LUMINAIR customers travelling across Europe, offering a spacious and comfortable cabin experience along with the reliability they need t
The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible21.4.2026 13:00:00 CEST | Press release
The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments21.4.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further expands the set of collaborations that Compass has established to inform the potential delivery of COMP360 in a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Osmind is a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. Osmind’s network of over 1,000 clinics comprises one of the country’s largest network of interventional psychiatry practices. Its
Aventon Expands B2B Payment Terms Program to Germany with TreviPay21.4.2026 11:00:00 CEST | Press release
Expansion builds on North American program success and brings flexible invoicing and net terms to Aventon’s growing retailer network in Europe TreviPay, a global B2B payments infrastructure partner, today announced the expansion of its partnership with Aventon to support the launch of the Aventon Payment Terms program in Germany. Building on the success of Aventon’s existing program in the US and Canada, the new offering will give qualified B2B buyers in Germany access to invoicing and flexible payment terms designed to make purchasing easier and more predictable. As Aventon enters the German market and expands its presence in Europe, TreviPay will serve as the exclusive provider of payment terms for Aventon’s B2B buyers. The program is designed to help Aventon’s retail partners buy more confidently and manage working capital more effectively, while supporting the brand’s long-term growth in a new geography. By offering trade credit through TreviPay, Aventon can give retailers greater
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom